IL15 and neoplasm: IL-15 agonists have demonstrated significant inhibition of tumor growth and anti-metastatic properties in preclinical studies and are currently undergoing clinical investigation (Guo et al., 2017; Fiore et al., 2020; Bergamaschi et al., 2021).